Mission indicators

  • M.1 Under-five mortality rate
  • M.2 Future deaths averted with Gavi support
  • M.3 Future disability-adjusted life years (DALYs) averted with Gavi support
  • M.4 Reduction in zero-dose children
  • M.5 Unique children immunised through routine immunisation with Gavi support
  • M.6 Economic benefits generated through Gavi-supported immunisations

EQUITY GOAL STRATEGY INDICATORS

  • S2.1 Geographic equity of third dose of diphtheria-tetanus-pertussis-containing vaccine (DTP3) coverage
  • S2.2 DTP drop-out
  • S2.3 Coverage of first dose of measles-containing vaccine (MCV1)
  • S2.4 Immunisation sessions conducted
  • S2.5 Stock availability at facility level
  • S2.6 Expanded Programme on Immunization (EPI) management capacity
  • S2.7 Implementation of tailored plans to overcome demand-related barriers
  • S2.8 Addressing gender-related barriers to immunisation

HEALTHY MARKETS GOAL STRATEGY INDICATORS

  • S4.1 Healthy market dynamics
  • S4.2 Incentivise innovations
  • S4.3 Scale up innovations

VACCINE GOAL STRATEGY INDICATORS

  • S1.1 Breadth of protection
  • S1.2 Vaccine coverage
    • Third dose of diphtheria-tetanus-pertussis (DTP)-containing vaccine (DTP3)
    • Second dose of measles-containing vaccine (MCV2)
    • Last dose in schedule of pneumococcal conjugate vaccine (PCV3)
    • Last dose in schedule of human papillomavirus vaccine (HPVC)
  • S1.3 Rate of scale-up of new vaccines
    • Last dose in schedule of pneumococcal conjugate vaccine (PCV3)
    • Last dose in schedule of rotavirus vaccine (RotavirusC)
    • Second dose of measles-containing vaccine (MCV2)
    • Yellow fever vaccine
  • S1.4 Vaccine introductions 
  • S1.5 Country prioritisation of vaccines 
  • S1.6 Measles campaign reach 
  • S1.7 Timely detection of and response to outbreaks

SUSTAINABILITY GOAL STRATEGY INDICATORS

  • S3.1 Co-financing fulfilment
  • S3.2 Preventing backsliding in Gavi-transitioned countries
  • S3.3 Vaccine introductions in Gavi-transitioned countries and never Gavi-eligible countries

Related documents

Gavi 5.0 Measurement Framework (2021–2025)

Download

Our 2021–2025 strategy

Phase 5 (2021–2025)

In June 2019, the Gavi Board approved a new five-year strategy (“Gavi 5.0”) with a vision of “Leaving no one behind with immunisation” and a mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines…

Gavi/2013/Adrian Brooks/Nigeria
Learn more
Last updated: 3 Feb 2023

Subscribe to our newsletter